Single molecule profiling of tau gene expression in Alzheimer's disease

Journal of Neurochemistry

Volumn 103, Issue 3, 2007, Pages 1228-1236

  Conrad, Chris ^a,f,g   Zhu, Jun ^b,f   Conrad, Cintia ^a   Schoenfeld, David ^a   Fang, Zhide ^c   Ingelsson, Martin ^a   Stamm, Stefan ^d   Church, George ^e   Hyman, Bradley T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEW ORLEANS   (United States)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e HARVARD MEDICAL SCHOOL   (United States)

^f NewYork Presbyterian Hospital   (United States)

^g DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Splicing; Tau

Indexed keywords

HTRA2 BETA1 PROTEIN; PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; EXON; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC PROCEDURES; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN TISSUE; POLONY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TAU GENE;

AGED; AGED, 80 AND OVER; ALTERNATIVE SPLICING; ALZHEIMER DISEASE; BIOLOGICAL ASSAY; BRAIN; BRAIN CHEMISTRY; EXONS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MITOCHONDRIAL PROTEINS; MOLECULAR BIOLOGY; PROTEIN ISOFORMS; SERINE ENDOPEPTIDASES; TAU PROTEINS;

EID: 35248862496     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04857.x     Document Type: Article

References (48)

1. Aach J. Church G. M. (2004) Mathematical models of diffusion-constrained polymerase chain reactions: basis of high-throughput nucleic acid assays and simple self-organizing systems. J. Theor. Biol. 228, 31 46.
2. Andreadis A., Broderick J. A. Kosik K. S. (1995) Relative exon affinities and suboptimal splice site signals lead to non-equivalence of two cassette exons. Nucleic Acids Res. 23, 3585 3593.
3. Baker M., Litvan I., Houlden H., Adamson J., Dickson D., Perez-Tur J., Hardy J., Lynch T., Bigio E. Hutton M. (1999) Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum. Mol. Genet. 8, 711 715.
4. Bertram L., Hiltunen M., Parkinson M. et al. (2005) Family-based association between Alzheimer's disease and variants in UBQLN1. N. Engl. J. Med. 352, 884 894.
5. Boutajangout A., Boom A., Leroy K. Brion J. P. (2004) Expression of tau mRNA and soluble tau isoforms in affected and non-affected brain areas in Alzheimer's disease. FEBS Lett. 576, 183 189.
6. Brandt R., Hundelt M. Shahani N. (2005) Tau alteration and neuronal degeneration in tauopathies: mechanisms and models. Biochimica et Biophysica Acta (BBA) - Mol. Basis Dis. 1739, 331 354.
7. Buee L., Bussiere T., Buee-Scherrer V., Delacourte A. Hof P. R. (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev. 33, 95 130.
8. Buhler J. D., Souvenir R. M., Zhang W. Mitra R. D. (2004) Design of a high-throughput assay for alternative splicing using polymerase colonies. Pac. Symp. Biocomput. 9, 5 16.
9. Caffrey T. M., Joachim C., Paracchini S., Esiri M. M. Wade-Martins R. (2006) Haplotype-specific expression of exon 10 at the human MAPT locus. Hum. Mol. Genet. 15, 3529 3537.
10. Chambers C. B., Lee J. M., Troncoso J. C., Reich S. Muma N. A. (1999) Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease. Ann. Neurol. 46, 325 332.
11. Connell J. W., Rodriguez-Martin T., Gibb G. M., Kahn N. M., Grierson A. J., Hanger D. P., Revesz T., Lantos P. L., Anderton B. H. Gallo J. M. (2005) Quantitative analysis of tau isoform transcripts in sporadic tauopathies. Brain Res. Mol. Brain Res. 137, 104 109.
12. Conrad C., Vianna C., Schultz C., Thal D. R., Ghebremedhin E., Lenz J., Braak H. Davies P. (2004) Molecular evolution and genetics of the Saitohin gene and tau haplotype in Alzheimer's disease and argyrophilic grain disease. J. Neurochem. 89, 179 188.
13. Couchie D., Charriere-Bertrand C. Nunez J. (1988) Expression of the mRNA for tau proteins during brain development and in cultured neurons and astroglial cells. J. Neurochem. 50, 1894 1899.
14. D'Souza I. Schellenberg G. D. (2005) Regulation of tau isoform expression and dementia. Biochimica et Biophysica Acta (BBA) - Mol. Basis. Dis. 1739, 104 115.
15. D'Souza I., Poorkaj P., Hong M., Nochlin D., Lee V. M. Y., Bird T. D. Schellenberg G. D. (1999) Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc. Natl Acad. Sci. 96, 5598 5603.
16. Fujino Y., Wang D. S., Thomas N., Espinoza M., Davies P. Dickson D. W. (2005) Increased frequency of argyrophilic grain disease in Alzheimer disease with 4R tau-specific immunohistochemistry. J. Neuropathol. Exp. Neurol. 64, 209 214.
17. Gentle A., Anastasopoulos F. McBrien N. A. (2001) High-resolution semi-quantitative real-time PCR without the use of a standard curve. Biotechniques 31, 502, 504 506, 508.
18. Ginsberg S. D., Che S., Counts S. E. Mufson E. J. (2006) Shift in the ratio of three-repeat tau and four-repeat tau mRNAs in individual cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease. J. Neurochem. 96, 1401 1408.
19. Glatz D. C., Rujescu D., Tang Y. et al. (2006) The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease. J. Neurochem. 96, 635 644.
20. Goedert M., Spillantini M. G., Jakes R., Rutherford D. Crowther R. A. (1989a) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3, 519 526.
21. Goedert M., Spillantini M. G., Potier M. C., Ulrich J. Crowther R. A. (1989b) Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J. 8, 393 399.
22. Hecker K. H. Roux K. H. (1996) High and low annealing temperatures increase both specificity and yield in touchdown and stepdown PCR. Biotechniques 20, 478 485.
23. Ingelsson M., Fukumoto H., Newell K. L., Growdon J. H., Hedley-Whyte E. T., Frosch M. P., Albert M. S., Hyman B. T. Irizarry M. C. (2004) Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology 62, 925 931.
24. Ingelsson M., Ramasamy K., Cantuti-Castelvetri I. et al. (2006) No alteration in tau exon 10 alternative splicing in tangle-bearing neurons of the Alzheimer's disease brain. Acta Neuropathol. 112, 439 449.
25. Klucken J., McLean P. J., Gomez-Tortosa E., Ingelsson M. Hyman B. T. (2003) Neuritic alterations and neural system dysfunction in Alzheimer's disease and dementia with Lewy bodies. Neurochem. Res. 28, 1683 1691.
26. Klucken J., Ingelsson M., Shin Y., Irizarry M. C., Hedley-Whyte E. T., Frosch M. P., Growdon J. H., McLean P. J. Hyman B. T. (2006) Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies. Acta Neuropathol. 111, 101 108.
27. Lander E. S., Linton L. M., Birren B. et al. (2001) Initial sequencing and analysis of the human genome. Nature 409, 860 921.
28. Laws S. M., Friedrich P., Diehl-Schmid J., Muller J., Eisele T., Bauml J., Forstl H., Kurz A. Riemenschneider M. (2006) Fine mapping of the MAPT locus using quantitative trait analysis identifies possible causal variants in Alzheimer's disease. Mol. Psychiatr. 12, 510 517.
29. LoPresti P., Szuchet S., Papasozomenos S. C., Zinkowski R. P. Binder L. I. (1995) Functional implications for the microtubule-associated protein tau: localization in oligodendrocytes. Proc. Natl Acad. Sci. USA 92, 10369 10373.
30. Maniatis T. Tasic B. (2002) Alternative pre-mRNA splicing and proteome expansion in metazoans. Nature 418, 236 243.
31. Mukherjee O., Kauwe J. S., Mayo K., Morris J. C. Goate A. M. (2007) Haplotype-based association analysis of the MAPT locus in late onset Alzheimer's disease. BMC Genetics 8, 3.
32. Muller R., Heinrich M., Heck S., Blohm D. Richter-Landsberg C. (1997) Expression of microtubule-associated proteins MAP 2 and tau in cultured rat brain oligodendrocytes. Cell Tissue Res. 288, 239 249.
33. Myers A. J., Kaleem M., Marlowe L. et al. (2005) The H1c haplotype at the MAPT locus is associated with Alzheimer's disease. Hum. Mol. Genet. 14, 2399 2404.
34. Myers A. J., Pittman A. M., Zhao A. S. et al. (2007) The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiol. Dis. 25, 561 570.
35. Nishimura T., Ikeda K., Akiyama H. et al. (1997) Glial tau-positive structures lack the sequence encoded by exon 3 of the tau protein gene. Neurosci. Lett. 224, 169 172.
36. Riessland M., Brichta L., Hahnen E. Wirth B. (2006) The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells. Hum. Genet. 120, 101 110.
37. Schindler H., Wiese A., Auer J. Burtscher H. (2005) cRNA target preparation for microarrays: comparison of gene expression profiles generated with different amplification procedures. Anal. Biochem. 344, 92 101.
38. Sergeant N., Sablonniere B., Schraen-Maschke S., Ghestem A., Maurage C. A., Wattez A., Vermersch P. Delacourte A. (2001) Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Hum. Mol. Genet. 10, 2143 2155.
39. Shendure J., Porreca G. J., Reppas N. B., Lin X., McCutcheon J. P., Rosenbaum A. M., Wang M. D., Zhang K., Mitra R. D. Church G. M. (2005) Accurate multiplex polony sequencing of an evolved bacterial genome. Science 309, 1728 1732.
40. de Silva R., Lashley T., Strand C. et al. (2006) An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R- and 4R-specific tau monoclonal antibodies. Acta Neuropathol. 111, 329 340.
41. Spillantini M. G., Murrell J. R., Goedert M., Farlow M. R., Klug A. Ghetti B. (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl Acad. Sci. USA 95, 7737 7741.
42. Stoilov P., Daoud R., Nayler O. Stamm S. (2004) Human tra2-beta1 autoregulates its protein concentration by influencing alternative splicing of its pre-mRNA. Hum. Mol. Genet. 13, 509 524.
43. Takanashi M., Mori H., Arima K., Mizuno Y. Hattori N. (2002) Expression patterns of tau mRNA isoforms correlate with susceptible lesions in progressive supranuclear palsy and corticobasal degeneration. Mol. Brain Res. 104, 210 219.
44. Umeda Y., Taniguchi S., Arima K., Piao Y. S., Takahashi H., Iwatsubo T., Mann D. Hasegawa M. (2004) Alterations in human tau transcripts correlate with those of neurofilament in sporadic tauopathies. Neurosci. Lett. 359, 151 154.
45. Unger J. W. (1998) Glial reaction in aging and Alzheimer's disease. Microsc. Res. Tech. 43, 24 28.
46. Wang Y., Wang J., Gao L., Lafyatis R., Stamm S. Andreadis A. (2005) Tau exons 2 and 10, which are misregulated in neurodegenerative diseases, are partly regulated by silencers which bind a SRp30c.SRp55 complex that either recruits or antagonizes htra2beta1. J. Biol. Chem. 280, 14230 14239.
47. Yasojima K., McGeer E. G. McGeer P. L. (1999) Tangled areas of Alzheimer brain have upregulated levels of exon 10 containing tau mRNA. Brain Res. 831, 301 305.
48. Zhu J., Shendure J., Mitra R. D. Church G. M. (2003) Single molecule profiling of alternative pre-mRNA splicing. Science 301, 836 838.